First therapy to be FDA-approved and EC-authorized for acquired hypothalamic obesity ---- European Commission grants authorization in adults ...

First therapy to be FDA-approved and EC-authorized for acquired hypothalamic obesity ---- European Commission grants authorization in adults and children 4 years of age and abo ...

A Texas A&M AgriLife survey of horse owners and industry professionals seeks to quantify the prevalence of equine endocrine ...

Beyond changes to your appearance, acromegaly causes “invisible” symptoms like joint pain and fatigue. Learn how to manage them and improve your quality of life.

Doctors want you to stop believing that cortisol is always to blame.

You can't see or taste them, but microplastics are in your blood, your brain, and possibly your mood. Here's what the science ...

Kisspeptin sits at the center of one of the most critical control systems in human reproduction, but it’s still widely ...

A brain MRI revealed that the cyst in the neurohypophysis gland had doubled in size, measuring 7 × 7.5 mm (versus 3.5 × 4 mm) ...

Week 1 of the menstrual cycle is a powerful hormonal reset. Falling progesterone, rising FSH, steady LH, and low oestrogen work together to prepare the body for ovulation. Understanding these early ...

Acromegaly requires multimodal management. While surgery is first-line, many patients have persistent/recurrent disease. Gamma knife radiosurgery (GKRS) offers precise radiation, but data on its use ...

Kisspeptin‑10 (KP‑10) is a short, bioactive cleavage product of the KiSS1 precursor peptide that has gained prominence as a central regulator of neuroendocrine systems.